TMO:NYE-Thermo Fisher Scientific Inc

EQUITY | Medical Diagnostics & Research | New York Stock Exchange

Last Closing

USD 263.81

Change

0.00 (0.00)%

Market Cap

USD 56.05B

Volume

1.74M

Analyst Target

USD 273.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Thermo Fisher Scientific Inc offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-24 )

Largest Industry Peers for Medical Diagnostics & Research

ETFs Containing TMO

XDNA 9.55 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 7.30 % 0.00 %

+0.32 (+0.00%)

USD 5.43M
LIFE-B:CA Evolve Global Healthcare .. 5.22 % 0.00 %

N/A

CAD 0.01B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.80 % 0.00 %

+0.22 (+0.00%)

USD 3.51M
BGU-U:CA Bristol Gate Concentrated.. 4.75 % 0.00 %

-0.05 (0.00%)

CAD 0.11B
XGES:LSE Xtrackers MSCI Genomic He.. 4.68 % 0.00 %

+0.30 (+0.00%)

USD 3.51M
AILG 4.51 % 0.00 %

N/A

N/A
XLV Health Care Select Sector.. 4.12 % 0.13 %

+0.53 (+0.00%)

USD 37.76B
GXLV:LSE SPDR® S&P® U.S. Health .. 4.11 % 0.00 %

+0.40 (+0.00%)

USD 0.39B
IUHC:SW iShares S&P 500 Health Ca.. 4.10 % 0.00 %

N/A

USD 2.07B
SXLV:SW SPDR S&P U.S. Health Care.. 4.10 % 0.00 %

+0.17 (+0.00%)

N/A
MHCD:CA Middlefield Healthcare Di.. 4.05 % 0.00 %

+0.01 (+0.00%)

CAD 0.16B
XY7D:XETRA Global X S&P 500® Covere.. 4.05 % 0.00 %

-0.04 (0.00%)

N/A
CWS AdvisorShares Focused Equ.. 4.04 % 0.68 %

+0.55 (+0.00%)

USD 0.14B
XUHC:SW Xtrackers MSCI USA Health.. 3.98 % 0.00 %

+0.45 (+0.00%)

USD 0.81B
IYH iShares U.S. Healthcare E.. 3.94 % 0.43 %

+0.27 (+0.00%)

USD 3.23B
WH2E:XETRA Invesco Markets II plc - .. 3.83 % 0.00 %

+0.05 (+0.00%)

USD 2.31M
FHLC Fidelity® MSCI Health Ca.. 3.62 % 0.08 %

+0.23 (+0.00%)

USD 2.94B
VHT Vanguard Health Care Inde.. 3.61 % 0.10 %

+1.20 (+0.00%)

USD 16.98B
PINK Simplify Exchange Traded .. 3.53 % 0.00 %

+0.20 (+0.00%)

USD 0.12B
DRUG:AU BetaShares Global Healthc.. 3.44 % 0.00 %

+0.09 (+0.00%)

USD 0.16B
WELG:XETRA Amundi S&P Global Health .. 3.14 % 0.00 %

+0.10 (+0.00%)

USD 0.24B
WELS:XETRA Amundi S&P Global Health .. 3.14 % 0.00 %

+0.10 (+0.00%)

USD 0.24B
CDNA:CA CI Bio-Revolution ETF 3.03 % 0.00 %

N/A

CAD 4.55M
HEAW:LSE SPDR® MSCI World Health .. 2.88 % 0.00 %

+0.64 (+0.00%)

USD 0.57B
WHEA:SW SPDR MSCI World Health Ca.. 2.87 % 0.00 %

N/A

N/A
DXGE:CA Dynamic Active Global Equ.. 2.82 % 0.00 %

+0.10 (+0.00%)

CAD 0.04B
ABIT:XETRA AXA IM ACT Biodiversity E.. 2.75 % 0.00 %

+0.02 (+0.00%)

USD 0.41B
ABIT:F AXA IM ACT Biodiversity E.. 2.75 % 0.00 %

+0.05 (+0.00%)

N/A
ABIE:F AXA IM ACT Biodiversity E.. 2.75 % 0.00 %

+0.07 (+0.00%)

N/A
ABIE:XETRA AXA IM ACT Biodiversity E.. 2.62 % 0.00 %

+0.01 (+0.00%)

N/A
MOAT:SW VanEck Morningstar US Sus.. 2.51 % 0.00 %

+0.53 (+0.00%)

N/A
DXQ:CA Dynamic Active Enhanced Y.. 2.25 % 0.00 %

+0.15 (+0.00%)

CAD 0.38B
PFUT Putnam Sustainable Future.. 2.13 % 0.00 %

+0.24 (+0.00%)

USD 0.23B
HYLG Global X Funds - Global X.. 1.92 % 0.00 %

-0.04 (0.00%)

USD 2.85M
DOCG:LSE L&G Healthcare Breakthrou.. 1.78 % 0.00 %

+7.25 (+0.00%)

USD 0.08B
DOCT:LSE L&G Healthcare Breakthrou.. 1.78 % 0.00 %

N/A

USD 0.08B
DFUV Dimensional US Marketwide.. 1.17 % 0.00 %

+0.32 (+0.00%)

USD 10.15B
JPST JPMorgan Ultra-Short Inco.. 0.74 % 0.00 %

+0.02 (+0.00%)

USD 22.73B
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

+1.10 (+0.00%)

USD 0.21B
IBLN 0.00 % 0.64 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.66 (+0.00%)

USD 4.11B
JHMH 0.00 % 0.46 %

N/A

N/A
LDUR PIMCO Enhanced Low Durati.. 0.00 % 1.02 %

+0.03 (+0.00%)

USD 0.89B
JMIN 0.00 % 0.12 %

N/A

N/A
LRGE ClearBridge Large Cap Gro.. 0.00 % 0.59 %

+0.45 (+0.00%)

USD 0.22B
ACT Enact Holdings Inc 0.00 % 0.75 %

+0.17 (+0.00%)

USD 4.70B
PVAL Putnam Focused Large Cap .. 0.00 % 0.29 %

+0.35 (+0.00%)

USD 0.31B
KORP American Century Diversif.. 0.00 % 0.45 %

+0.11 (+0.00%)

USD 0.26B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.08B
LS:CA Middlefield Healthcare & .. 0.00 % 2.21 %

N/A

CAD 0.16B
HWF:CA 0.00 % 0.00 %

N/A

N/A
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.00 %

-0.18 (0.00%)

CAD 0.02B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.08 (0.00%)

USD 1.09M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.08 (0.00%)

USD 1.09M
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.69 (+0.00%)

USD 0.09B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.54 (+0.00%)

CAD 0.58B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.19 (+0.00%)

CAD 0.01B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+11.63 (+0.00%)

USD 1.69B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

+0.07 (+0.00%)

USD 2.07B
MOAT:LSE VanEck Morningstar US Sus.. 0.00 % 0.00 %

-0.05 (0.00%)

USD 0.53B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.23 (+0.00%)

USD 0.40B
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

+0.48 (+0.00%)

USD 0.59B
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.36 (+0.00%)

USD 2.64B
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

+44.00 (+0.00%)

USD 0.36B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+51.50 (+0.00%)

USD 1.04B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.28 (+0.00%)

USD 1.04B
XVTD:LSE Xtrackers - FTSE Vietnam .. 0.00 % 0.00 %

+0.57 (+0.00%)

USD 0.36B
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.08 (+0.00%)

USD 2.09B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.52 (+0.00%)

USD 2.60B
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.41 (+0.00%)

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.34 (+0.00%)

USD 0.40B
DXSI:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

+0.76 (+0.00%)

USD 0.02B
GMVM:XETRA VanEck Morningstar US Sus.. 0.00 % 0.00 %

+0.13 (+0.00%)

USD 0.53B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.08 (+0.00%)

USD 2.05B
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.47 (+0.00%)

USD 2.60B
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.36 (+0.00%)

USD 0.85B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.28 (+0.00%)

USD 0.40B
PBI-B:CA Purpose Fund Corp. - Purp.. 0.00 % 0.00 %

-0.52 (0.00%)

CAD 8.10M
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

+0.05 (+0.00%)

USD 0.07B
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+1.04 (+0.00%)

USD 1.35B
DWEQ 0.00 % 0.00 %

N/A

N/A
MOGB:LSE VanEck Morningstar US Sus.. 0.00 % 0.00 %

+0.32 (+0.00%)

USD 0.53B
SROI Calamos Antetokounmpo Glo.. 0.00 % 0.00 %

+0.25 (+0.00%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.88% 41% F 80% B-
Dividend Return 0.08% 33% F 2% F
Total Return 17.97% 41% F 79% B-
Trailing 12 Months  
Capital Gain 28.91% 76% C+ 94% A
Dividend Return 0.34% 17% F 3% F
Total Return 29.25% 76% C+ 93% A
Trailing 5 Years  
Capital Gain 118.66% 71% C- 94% A
Dividend Return 2.59% 14% F 9% A-
Total Return 121.24% 71% C- 93% A
Average Annual (5 Year Horizon)  
Capital Gain 17.46% 76% C+ 90% A-
Dividend Return 17.88% 76% C+ 88% B+
Total Return 0.43% 14% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 10.41% 94% A 65% D
Risk Adjusted Return 171.70% 94% A 98% N/A
Market Capitalization 56.05B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.09 29% 15%
Price/Book Ratio 3.95 41% 18%
Price / Cash Flow Ratio 5.87 59% 17%
Price/Free Cash Flow Ratio 28.06 53% 17%
Management Effectiveness  
Return on Equity 10.98% 53% 62%
Return on Invested Capital 8.60% 47% 51%
Return on Assets 5.26% 47% 71%
Debt to Equity Ratio 73.00% 41% 50%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.